About the speakers
Gary is a Partner and investment manager in the US Equities team. He graduated MBiochem in Biochemistry from the University of Oxford in 2003 and joined Baillie Gifford the same year. He spent time working on our Japanese, UK and European Equity teams before moving to the US Equities team in 2008. Gary is a generalist investor but retains a special interest in the healthcare sector dating back to his undergraduate degree. Gary is also a member of the Global Stewardship Portfolio Construction Group.
Related insights
The case for private growth equity
How companies like Stripe, Databricks and SpaceX are shaking up growth trends typically dominated by public markets.April 2025
Video|38 minutes
US Alpha Q1 update
The US Alpha Team reflects on recent performance, portfolio changes and market developments.April 2025
Video|9 minutes
US Equity Growth Q1 update
The US Equity Growth Team reflects on recent performance, portfolio changes and market developments.April 2025
Video |10 minutes